Evotec SE Gets New Finance Chief
German Biotech Evotec Names New CFO
02:45 AM EST, 02/07/2023 (MT Newswires) -- Evotec (EVT.F) said Tuesday that its board has appointed Laetitia Rouxel as the new chief financial officer, effective April 1. Rouxel will succeed Enno Spil
Evotec SE Named Industry Veteran Laetitia Rouxel as CFO Effective April 1; Former Finance Chief Enno Spillner Will Depart To Pursue Other Opportunities
Evotec SE ((Frankfurt Stock Exchange: EVT, MDAX/TecDAX, OTC:EVOTF, NASDAQ:EVO) announced today that the Company's Supervisory Board has appointed Laetitia Rouxel as new Chief Financial Officer and mem
Evotec SE: Laetitia Rouxel to Succeed Enno Spillner as Chief Financial Officer
HAMBURG, GERMANY / ACCESSWIRE / February 7, 2023 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company's Supervisory Board has appoi
Evotec SE Appoints Laetitia Rouxel As CFO
Evotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $9.81
Evotec SE (OTCMKTS:EVTCY – Get Rating)'s share price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $9.81 and last traded at $9.85, with a volume of 6946 shares.
Analysts Conflicted on These Healthcare Names: Can-Fite BioPharma (CANF), CareDx (CDNA) and Evotec AG (EVO)
Evotec Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Evotec Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Evotec Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/27/2023 16.05% HC Wainwright & Co. → $12 Reiterates → Buy 12/09/2022 16.05% HC Wainwright & Co. → $12 I
HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $12 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Evotec with a Buy and maintains $12 price target.
Loading...
No Stock Yet